Join us for the Colorectal Cancer Community Conference on May 18th & 19th. Click here for complimentary registration.

Blog banner Blog banner

Hepatic Artery Infusion pumps in patients with colorectal cancer with liver metastases

22 December 2020 Hepatic Artery Infusion (HAI) chemotherapy is sometimes used as adjuvant treatment (treatment that accompanies the primary treatment to increase its effectiveness) in combination with systemic chemotherapy for the treatment of colorectal liver metastases. Hepatic Artery Infusion (HAI) involves the continuous...

CONTINUE READING

“Test all patients with cancer”: 1 in 8 have inherited mutations

November 2020 Findings from a recent study conducted by the Mayo Clinic found that while about 1 in 8 patients with cancer have an inherited genetic mutation that likely contributed to the development of their cancer, nearly half of these mutations would have been missed under current clinical guidelines. The study was the...

CONTINUE READING

Rectal cancer management: do all patients need to undergo surgery?

The non-surgical management or  “watch-and-wait” approach for rectal cancer is an experimental treatment strategy that aims to safely omit invasive surgical procedures to best preserve patients’ quality of life. Findings from a recent study add to the growing body of evidence that supports the “watch-and-wait” approach in re...

CONTINUE READING

Palliative care for young adults is a growing reality in CRC

The incidence of colorectal cancer (CRC) is rising among young adults, who remain a vulnerable subset of patients that tends to be diagnosed at more advanced stages of the disease. As early age onset CRC becomes a growing reality, it is critical that psychosocial, palliative and supportive care needs of these patients are addres...

CONTINUE READING

OPTIMISTICC Research Program sheds light on importance of gut microbiome in colorectal cancer development and treatment

Opportunity to Investigate the Microbiome’s Impact on Science and Treatment in Colorectal Cancer (OPTIMISTICC) Research Program sheds light on the importance of the gut microbiome in colorectal cancer development and treatment. This research program is an international collaboration that spans 5 countries and is working toget...

CONTINUE READING

Sponsors